David Braxton, MD, FCAP, discusses an AI-based molecular profiling technology to improve the delivery of cancer patient care and outcomes. “Traditional molecular biomarker testing is expensive and can take weeks for patients to receive their results," said Dr. Braxton.
For the full article click here: Hoag to use AI profiling to expedite cancer care for patients